TLRY Tilray

Good Supply™ Cannabis Launches 'Get Blitzen’d' Holiday Campaign and New Limited-Edition Products Across Canada

Good Supply™ Cannabis Launches 'Get Blitzen’d' Holiday Campaign and New Limited-Edition Products Across Canada

Ignite this Year’s Holiday Festivities with Good Supply’s ‘Holiday Helper’ 36 Pre-Roll Mix Pack and ‘The Grump’ MONSTERS 1000mg Infused Pre-rolls

TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that its best-selling Canadian cannabis brand, , just unveiled a new seasonal campaign, ‘Get Blitzen’d’. Amplifying the festive cheer, Good Supply introduces its first-ever limited-edition 'Holiday Helpers' 36-pack of pre-rolls and 'The Grump' - a special holiday offering of the acclaimed 1,000mg infused pre-roll.

Good Supply’s ‘Holiday Helpers’ Pre-roll Mix pack:

In the spirit of the ‘12 Days of Jointmas’, Good Supply launches its new ‘Holiday Helpers’ pre-roll mix pack (36 x 0.35g). This carefully curated selection offers 12 pre-rolls of each of Good Supply’s best-selling sativa, hybrid, and indica blends (36 x 0.35g) – including Jean Guy, Lava Fuel, and Wedding Cake, providing a trio of high-quality daily options for connoisseurs seeking diverse experiences throughout the holiday season.

Good Supply’s ‘The Grump’ MONSTERS:

Building on the success of the original 'MONSTERS' launch, Good Supply introduces 'The Grump', a 2.38g infused pre-roll, evoking the essence of holiday storytelling. Each pre-roll contains the most THC allowed in one package, at 1,000mg of THC 1. It features Monkey Glue milled flower infused with Sweet Berry Kush BHO (Monkey Glue x Sweet Berry Kush), perfectly rolled and coated in extract, followed by kief.

Good Supply infuses the festive spirit into its 'Get Blitzen'd' holiday campaign with the release of the 'Holiday Helpers' pre-roll mix pack and 'The Grump' pre-rolls. Both are hitting shelves nationwide, with 'Holiday Helpers' available in Ontario and Alberta, while 'The Grump' will be available in Ontario, Alberta, British Columbia, Nova Scotia, Saskatchewan, Manitoba, and Newfoundland and Labrador.

To add Good Supply’s limited-time releases to your wish list this festive season and to keep up with the brand’s latest launches, visit  and follow @goodsupplycannabis.

About Good Supply

Good Supply is one of Canada's leading cannabis brands and been recognized as #1 in flower, and best-selling pre-rolls, vapes, and concentrates, and has become a favourite among consumers and budtenders. At Good Supply, good is the new great. Rooted in classic strains that punch above their weight, Good Supply delivers consistent, hard-hitting quality at affordable prices. Explore classic strains, innovative formats, and new flavours – we’re always up for a good time. The Good Supply™ brand is produced in accordance with a Health Canada cannabis processing and cultivation license held by Aphria Inc., a subsidiary of Tilray Brands, Inc.

About Tilray Brands

 Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information on Tilray, visit  and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

Contacts:

Media:

Kaitlin Macapagal

Investors

Raphael Gross

203-682-8253


1 “The most THC allowed in one package” – Health Canada, proposed regulations for additional cannabis products available at:

 



EN
09/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray, ein weltweit führendes Unternehmen im Bereich medizinisches Ca...

Tilray, ein weltweit führendes Unternehmen im Bereich medizinisches Cannabis, gibt die Erweiterung der Produktion von hochwertigem Craft-Cannabis in seiner modernen EU-GMP-Anlage in Deutschland bekannt. Tilray Medical erweitert das Craft-Cannabis-Portfolio von Tilray um neue patientenorientierte Angebote NEUMÜNSTER, Deutschland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von  (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Zusammenarbeit zwischen Patienten und Ärzten fördert, um fundierte, individu...

 PRESS RELEASE

Tilray, leader mondial du cannabis médical, annonce l’expansion de sa ...

Tilray, leader mondial du cannabis médical, annonce l’expansion de sa gamme de cannabis Craft haut de gamme dans son centre de production en Allemagne, conforme aux normes BPF de l’UE. Tilray Medical enrichit le portefeuille de produits à base de cannabis de Tilray Craft grâce à de nouvelles offres axées sur les patients NEUMÜNSTER, Allemagne, 01 oct. 2025 (GLOBE NEWSWIRE) -- Tilray Medical, une division de  (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de santé de prendre ensemble des décisions de santé individu...

 PRESS RELEASE

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Pr...

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray...

 PRESS RELEASE

Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financi...

Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025 NEW YORK and LEAMINGTON, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the first quarter which ended August 31, 2025 before the financial markets open on Thursday, October 9, 2025. Live Conference Call and Audio Webcast Tilra...

 PRESS RELEASE

Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfes...

Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup ATLANTA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: TLRY and TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is raising a stein to the season with a festive lineup of Oktoberfest-inspired craft brews from its celebrated craft beer portfolio. As the leaves turn and the air crisps, Tilray invites beer lovers to embrace the spirit of fall with brews that blend German tradition and local creativity, perfect for fireside chats, backyard gatherings, and every “Ein Prosit” in bet...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch